Industry insights, all in one place.

The retina is the only place in the body where blood vessels and neural tissue can be seen non-invasively. A decade of clinical AI development has turned that insight into FDA-cleared diagnostic tools.

February 1, 2026

Clinical validation proves a technology works. Real-world deployment reveals whether it works in your system. Four lessons from large health system rollouts of autonomous AI retinal screening.

January 15, 2026

Sensitivity and specificity are the two numbers that define any diagnostic test. In diabetic retinopathy screening, one of them matters far more than the other — and knowing which one shapes how you evaluate AI tools.

January 1, 2026

Over 85% of patients are comfortable receiving a result from an autonomous AI system — but acceptance is significantly higher when the technology is explained upfront. What patient data tells us about trust and experience.

December 15, 2025